Legal Representation
Attorney
Brian T. Jaenicke
USPTO Deadlines
Application History
37 events| Date | Code | Type | Description |
|---|---|---|---|
| Nov 13, 2017 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED |
| Nov 13, 2017 | MAB6 | O | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED |
| Apr 8, 2017 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Apr 6, 2017 | EX5G | S | SOU EXTENSION 5 GRANTED |
| Mar 27, 2017 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Mar 27, 2017 | EXT5 | S | SOU EXTENSION 5 FILED |
| Sep 30, 2016 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Sep 29, 2016 | EX4G | S | SOU EXTENSION 4 GRANTED |
| Sep 23, 2016 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Sep 23, 2016 | EXT4 | S | SOU EXTENSION 4 FILED |
| Apr 20, 2016 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Apr 19, 2016 | EX3G | S | SOU EXTENSION 3 GRANTED |
| Apr 5, 2016 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Apr 5, 2016 | EXT3 | S | SOU EXTENSION 3 FILED |
| Oct 1, 2015 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Sep 30, 2015 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Sep 30, 2015 | EX2G | S | SOU EXTENSION 2 GRANTED |
| Sep 24, 2015 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Sep 24, 2015 | EXT2 | S | SOU EXTENSION 2 FILED |
| Mar 27, 2015 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Mar 25, 2015 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Mar 25, 2015 | EXT1 | S | SOU EXTENSION 1 FILED |
| Mar 25, 2015 | EX1G | S | SOU EXTENSION 1 GRANTED |
| Oct 7, 2014 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Aug 12, 2014 | PUBO | A | PUBLISHED FOR OPPOSITION |
| Aug 12, 2014 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Jul 23, 2014 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Jul 8, 2014 | ALIE | A | ASSIGNED TO LIE |
| Jul 8, 2014 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Jun 18, 2014 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Jun 17, 2014 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN |
| Jun 17, 2014 | GNEA | F | EXAMINERS AMENDMENT E-MAILED |
| Jun 17, 2014 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Jun 17, 2014 | XAEC | I | EXAMINER'S AMENDMENT ENTERED |
| Jun 16, 2014 | DOCK | D | ASSIGNED TO EXAMINER |
| Mar 24, 2014 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Mar 14, 2014 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 005
Human pharmaceuticals for the prevention or treatment of viral diseases, auto-immune and inflammatory diseases, cardiovascular diseases, central nervous system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, ophthalmic diseases and respiratory diseases
First Use Anywhere:
0
First Use in Commerce:
0
Additional Information
Translation
The wording "LYFTIC" has no meaning in a foreign language.
Classification
International Classes
005